Loading…
Dover Corporation
S&P 500
🏹 Trader: 🎯 Near 52W High View all →
$27.7B
Market Cap
24.6
P/E
1.39
PEG
12.8%
ROCE
15.3%
ROE
0.35
D/E
17.0%
OPM
-11.9%
% from 52W High
52
α RS
🔍 DOV is showing a high-conviction setup because it matches 7 of 37 tracked screener presets, it's within 11.9% of its 52-week high, and it's hugging the 21 EMA. Net: Broad signal stack, not a recommendation. ? Conviction 52W High Technicals
Sources
Conviction 7/37 · 11.9% from 52W high · hugging 21 EMA
⚖️ Compare 🔒 Generate Report 🔒 Research Packet 📚 Guides
🌏 Global Investor Returns
Currency-adjusted total returns for DOV including FX impact
🌏
Click 🌏 Returns tab to load data
📈 Price History
Ratio Health
Excellent
Good
Average
Poor
By Category
📊 Sector Averages
About

Dover Corporation provides equipment and components, consumable supplies, aftermarket parts, software and digital solutions, and support services worldwide.

Key Ratios Snapshot
📈 Growth Pattern
📊 Quick Scorecard
Loading…
🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
🎙 Management Tone Confident Specific → Stable 5 quarters Full tone analysis in Intelligence →
Good quarter Investor Presentation One-Pager? Q2 2026
Revenue
$2.19B
+7% YoY
GAAP earnings from continuing operations
$313M
+12% YoY
GAAP diluted EPS from continuing operations
$2.31
+14% YoY
Adjusted diluted EPS
$2.74
+12% YoY
Adjusted EBITDA margin
25.9%
+80 bps YoY
What Went Right
  • All five segments posted positive organic growth; total revenue grew 7% and organic growth was 5%.
  • Bookings increased 16% YoY with book-to-bill of 1.06, broad-based across all five segments.
  • Adjusted EPS rose 12% to $2.74 and adjusted EBITDA margin expanded 80 bps to 25.9%.
  • Incremental margins improved to 38% from 25% in Q1, helped by secular-growth mix.
What to Watch
  • Refrigeration production throughput shortfall during facility consolidation and labor ramp cost roughly 1-1.5 points of consolidated organic growth.
  • Polymer Processing had a tough comp and muted segment growth; management expects return to growth in H2.
  • Management highlighted uncertainty from geopolitics, input costs, and evolving trade/tariff background.
  • Absolute booked orders declined sequentially in Q2, though management downplayed it as revenue base growth.
Management Guidance
  • Full-year GAAP EPS raised to $8.94-$9.14 and adjusted EPS to $10.55-$10.75.
  • Full-year revenue growth guidance raised to 6%-8% with organic growth of 4%-6%.
  • Expects positive organic growth across all five segments and refrigeration throughput recovery in H2.
Investor Lens
The thesis is stronger after this call. Bookings growth of 16% and book-to-bill of 1.06 across all segments provide unusual visibility, and secular-growth markets now represent ~25% of revenue. The raise in full-year adjusted EPS guidance shows confidence in converting order momentum into earnings. The refrigeration execution miss is a self-inflicted, temporary issue that management expects to recover in H2, not a demand problem.
From investor presentation · AI-generated analysis · Not investment advice
🔒
Premium Feature
Investor Presentation One-Pager — quarterly highlights, what went right/wrong & management guidance
Upgrade to Premium
Already a member? Log in
📈 STRONG Strong quarter: 12% adjusted EPS growth, 1.06 book-to-bill, guidance raised.
Revenue
Revenue was $2.19B, up 7% YoY, with organic growth of 5%. All five segments grew organically, led by Clean Energy & Fueling (+9%) and Climate & Sustainability Technologies (+8%).
Profitability
GAAP earnings from continuing operations were $313M, up 12% YoY. Adjusted EPS was $2.74, up 12%, with adjusted earnings of $372M.
Margins
Adjusted EBITDA margin expanded 80 bps to 25.9%. Incremental margins were 38%, up from 25% in Q1, reflecting favorable mix and productivity.
Balance Sheet
Year-to-date free cash flow was $320M, or 8% of revenue, up 23% YoY. CapEx guidance remains $190M-$210M and free cash flow guidance is 14%-16% of revenue.
Key Risks
Refrigeration throughput shortfall and facility consolidation costs were the main operational risk, costing ~1-1.5 points of organic growth. Management also cited geopolitical uncertainty, input cost inflation, and tariff changes as factors to manage.
Outlook
Full-year adjusted EPS guidance was raised to $10.55-$10.75 with revenue growth of 6%-8% and organic growth of 4%-6%. Management expects refrigeration throughput and margins to improve materially in H2.
Generated by AI · Q2 2026 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter
🔍
🔎 See cross-company document search → ?
📞 Earnings Call Transcripts (5)
Q2 2026 Q2 2026 2026-07-23
Revenue grew 7% year-over-year with all segments posting organic growth and adjusted EPS up 12%. Bookings rose 16% and the book-to-bill ratio remained strong at 1.06, supporting a raised full-year EPS outlook. Secular growth markets and capacity expansions are driving future momentum.
Q1 2026 Q1 2026 2026-04-23
Q1 2026 saw double-digit revenue growth and record bookings, with strong performance in Clean Energy, Climate, and Engineered Products segments. Adjusted EPS rose 11% year-over-year, and full-year guidance was reaffirmed, with robust demand and a healthy order book supporting a positive outlook.
Q4 2025 Q4 2025 2026-01-29
Fourth quarter 2025 delivered strong organic growth, margin expansion, and robust free cash flow, with all segments showing bookings growth and double-digit EPS gains. 2026 guidance calls for continued double-digit EPS growth, strong cash conversion, and further productivity and M&A benefits.
Q3 2025 Q3 2025 2025-10-23
Q3 saw 5% revenue growth, record 26.1% EBITDA margin, and 15% higher adjusted EPS, with all segments improving margins. Bookings rose 8% year-over-year, and full-year EPS guidance was raised. Acquisitions and productivity initiatives are fueling growth into 2026.
Q2 2025 Q2 2025 2025-07-24
Q2 delivered strong margin and EPS growth, with bookings up 7% year-over-year and robust free cash flow. Guidance for full-year adjusted EPS was raised, supported by strong demand in growth platforms and ongoing productivity actions.
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Catalyst Timeline.

Every result, order win, insider trade, ECS update, earnings-call, and SEC announcement for this company — in one chronological lane.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

Financial Model
Projections are built from each company's audited annual financials (Income Statement, Balance Sheet, Cash Flow) over the last 5 fiscal years. Forward assumptions — revenue growth %, EBITDA margin, D&A (USD millions), interest expense, tax rate, and capex — are AI-generated using historical context and refreshed twice a year: after the December results season and after the September/Q4 results season.

DCF Valuation
Fair Value = Σ(FCFt / (1+WACC)t) + Terminal Value. Terminal Value uses the Gordon Growth Model: FCF5 × (1+g) / (WACC−g). Default WACC: 10% (US risk-free ~4.5%, equity risk premium ~5.5%). Default terminal growth: 3% (long-run US nominal GDP proxy).

CAGR Tracker
Expected 5-year CAGR = (DCF Fair Value / Current Price)1/5 − 1. Assumes fair value is reached in exactly 5 years — a mechanical estimate only.

Data Sources & Limitations
Financial statements sourced from public filings. Prices updated daily. Forward assumptions are AI-generated. All monetary values in USD millions. Non-US ADR companies may have currency conversion inaccuracies. Models are point-in-time and do not update intra-quarter or account for M&A, macro shocks, or extraordinary items.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.